医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

in Greater China

Visus Therapeutics, Inc., and Zhaoke Ophthalmology Limited Announce Exclusive Licensing Agreement to Commercialize BRIMOCHOL™ PF and Carbachol PF in Greater China, South Korea and Select Southeast Asian Markets for the Treatment of Presbyopia

Visus Therapeutics, Inc., and Zhaoke Ophthalmology Limited Announce Exclusive Licensing Agreement to Commercialize BRIMOCHOL™ PF and Carbachol PF in Greater China, South Korea and Select Southeast Asian Markets for the Treatment of Presbyopia

ヘルスケア眼科医療製薬　 TimeLine: and Zhaoke Ophthalmology Limited Announce Exclusive Licensing Agreement to Commercialize BRIMOCHOL in Greater China Inc.PF and Carbachol PF Visus Therapeutics

2022年05月11日

Sesen Bio announces an exclusive license agreement with Qilu Pharmaceutical for the development and commercialization of Vicineum™ in Greater China

Sesen Bio announces an exclusive license agreement with Qilu Pharmaceutical for the development and commercialization of Vicineum™ in Greater China

バイオテクノロジーヘルスケア感染症腫瘍学臨床試験製薬　 TimeLine: in Greater China Sesen Bio announces an exclusive license agreement with Qilu Pharmaceutical for the development and commercialization of Vicineum

2020年07月31日

Puma Biotechnology and CANbridge Life Sciences Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Greater China

その他ヘルスバイオテクノロジーヘルスケアヘルス一般腫瘍学製薬　 TimeLine: in Greater China Licensing Agreement to Commercialize NERLYNX Puma Biotechnology and CANbridge Life Sciences

2018年02月02日

Novacyt and Leica Biosystems Sign Major Distribution Deal for NOVAprep® in Greater China

Novacyt and Leica Biosystems Sign Major Distribution Deal for NOVAprep® in Greater China

バイオテクノロジーヘルスケアマネージド・ケア医療用品腫瘍学　 TimeLine: in Greater China Novacyt and Leica Biosystems Sign Major

2015年03月04日